For: | Zelber-Sagi S, Shoham D, Zvibel I, Abu-Abeid S, Shibolet O, Fishman S. Predictors for advanced fibrosis in morbidly obese non-alcoholic fatty liver patients. World J Hepatol 2017; 9(2): 91-98 [PMID: 28144390 DOI: 10.4254/wjh.v9.i2.91] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v9/i2/91.htm |
Number | Citing Articles |
1 |
Maria AL de Carli, Luiz A. de Carli, Marcos B. Correa, Gerson Junqueira, Cristiane Valle Tovo, Gabriela P. Coral. Performance of noninvasive scores for the diagnosis of advanced liver fibrosis in morbidly obese with nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2020; 32(3): 420 doi: 10.1097/MEG.0000000000001519
|
2 |
Michelle L. Aktary, Lindsay K. Eller, Alissa C. Nicolucci, Raylene A. Reimer. Cross-sectional analysis of the health profile and dietary intake of a sample of Canadian adults diagnosed with non-alcoholic fatty liver disease. Food & Nutrition Research 2020; 64(0) doi: 10.29219/fnr.v64.4548
|
3 |
Yoonjin Nam, Sung Kwon Ko, Uy Dong Sohn. Hepatoprotective effect of ultrasonicated ginseng berry extract on a rat mild bile duct ligation model. Journal of Ginseng Research 2019; 43(4): 606 doi: 10.1016/j.jgr.2018.07.007
|
4 |
Guangya Chen, Yi Lv, Wei Ni, Qingxin Shi, Xingliang Xiang, Sen Li, Chengwu Song, Mingzhong Xiao, Shuna Jin. Associations between Phase Angle Values Obtained by Bioelectrical Impedance Analysis and Nonalcoholic Fatty Liver Disease in an Overweight Population. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/8888405
|
5 |
Oksana S. Khukhlina, Oksana D. Liakhovych, Ludmila V. Kaniovska, Olena V. Kaushanska, Alona A. Antoniv, Vera O. Shuper. FEATURES OF SOME ANTHROPOMETRIC INDICES AND INDICES OF INSULIN RESISTANCE IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS ON THE BACKGROUND OF OBESITY AND OSTEOARTHRITIS. Wiadomości Lekarskie 2020; 73(4): 746 doi: 10.36740/WLek202004123
|
6 |
Cristina M. Muzica, Catalin Sfarti, Anca Trifan, Sebastian Zenovia, Tudor Cuciureanu, Robert Nastasa, Laura Huiban, Camelia Cojocariu, Ana-Maria Singeap, Irina Girleanu, Stefan Chiriac, Carol Stanciu, Branka Filipović. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/6638306
|
7 |
Qingzhi Huang, Hana Yu, Xin Zhong, Ying Tian, Zhenhua Cui, Zhenyu Quan. Association between hypertension and nonalcoholic fatty liver disease: a cross-sectional and meta-analysis study. Journal of Human Hypertension 2022; 37(4): 313 doi: 10.1038/s41371-022-00686-w
|
8 |
Flavio A. Cadegiani. Dietary Interventions in Liver Disease. 2019; : 39 doi: 10.1016/B978-0-12-814466-4.00004-5
|
9 |
Qi-Rui Song, Shuo-Lin Liu, Ya-Guang Bi, Shuo-Hua Chen, Shou-Ling Wu, Jun Cai. Non-alcoholic Fatty Liver Disease Is Associated With Cardiovascular Outcomes in Subjects With Prediabetes and Diabetes: A Prospective Community-Based Cohort Study. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.889597
|
10 |
Chun Kit Hung, Henry C. Bodenheimer. Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Clinics in Liver Disease 2018; 22(1): 175 doi: 10.1016/j.cld.2017.08.012
|
11 |
Kara Wegermann, Ricardo Henao, Anna Mae Diehl, Susan K. Murphy, Manal F. Abdelmalek, Cynthia A. Moylan, Pavel Strnad. Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study. PLOS ONE 2018; 13(9): e0204308 doi: 10.1371/journal.pone.0204308
|
12 |
Diego Meneses, Antonio Olveira, Ramon Corripio, María del Carmen Méndez, Míriam Romero, Isabel Calvo-Viñuelas, Lucrecia Herranz, David Vicent, Ana Isabel de-Cos-Blanco. Performance of Noninvasive Liver Fibrosis Scores in the Morbid Obese Patient, Same Scores but Different Thresholds. Obesity Surgery 2020; 30(7): 2538 doi: 10.1007/s11695-020-04509-0
|